Go to navigation
Go to content
Astrazeneca Worldwide
AstraZeneca Websites
Search
Main navigation
Home
Therapy Areas
Oncology/Infection
Cardiovascular
Gastrointestinal
Neuroscience
Respiratory/Inflammation
Drug Products
All Drug Products
Diseases & Conditions
All Diseases and Conditions
Glossary
Contact Us
Disclosure Commitment
You are here
Home
Therapy Areas
Gastrointestinal
A Randomised, Single Blind, Two-way Cross-over, Single-centre Study to Assess the Pharmacodynamics (Intragastric pH) and Pharmacokinetics After Repeated Oral Administration of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects
Drug Name
Nexium
Generic Name
Omeprazole
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
I
Start Date
Jan 18, 1971
Study Name
D961HC00009
Study Id
D961HC00009
ClinicalTrials.gov ID
NCT01159145
Recruiting Status
Closed
Protocol Status
Not Available
Report
Nov 2, 2010
D961HC00009.pdf
(518 KB)
Page tools
Print
Bookmark this page